Investors in Science

ALSA Ventures invest in biotechnology companies passionate about bringing novel therapies to patients. ALSA Ventures is a life science venture capital investor, focused on early stage novel therapeutics. With a strong operations background in drug development, our team seeks to bring together outstanding entrepreneurs and world class academic researchers to help bring promising new treatments to market. We invest across a wide spectrum of therapeutic areas, targeting high unmet need with impactful outcomes for patients and society at large.

Alder Hey Innovation Lab is an accelerator that provides pediatric healthcare solutions for children and young people. Alder Hey Children’s Hospital enjoys an International Reputation in many disciplines and has over the last few years become recognised as a leader in healthcare innovation. With the new hospital’s state of the art digital infrastructure, clinical entrepreneurs, dedicated commercial innovation team and active engagement with industry, academia and the local community we have created a true exemplar of the power of public and private collaboration and partnerships for accelerating innovation into healthcare.

Research center in nanoelectronics. Imec is a world-leading R&D and innovation hub in nanoelectronics and digital technologies. At times, we shape the future. Founded in 1984, imec quickly made its name as the leading research hub for advanced CMOS scaling. We will continue to shape the roadmap for the semiconductor industry for years to come.

Startup hub focussed on Life Sciences, Artificial Intelligence, and Industry Tech. The Technology Park is run by the Technologiepark Heidelberg GmbH, a joint venture by the City of Heidelberg and the Rhine-Neckar Chamber of Commerce and Industry (IHK), which with its wide-ranging services and active networking is committed to promoting the rapid growth of this base for cutting-edge science and technology.

German Accelerator empowers German startups to scale globally. We take high-potential companies on a fast-paced learning journey to understand, discover, and access the world’s leading innovation hubs in the U.S., Asia, and South America. Through highly-customized programs, mentoring from dedicated experts, as well as access to our vast network of business partners and investors.

Bio & Tech Smart Capital fund focused on life sciences and early-stage investments, providing their investors access to exceptional value investment opportunities. They aim to contribute to the development of the Galician life sciences sector, one of the fastest growing in Europe, while benefiting from its rapid growth and exceptional value. Their team consists of entrepreneurs with sector experience who contribute to their investee companies not only with funding but also with management experience, extensive networks, market access, and subject matter knowledge.

Full-scale acceleration services with major focus on Life Sciences. The founders of the Creative Accelerator Incubator all have successful entrepreneurial backgrounds. During their career so far, they have built and financed many companies that are decisive in their fields (for example, SAP America, Lombard Lízing Csoport, Solvo Biotechnológiai Zrt.

DSV is a venture studio and a fund that develops a systematic, optimized approach to science company development and investment. We are creating a future where humanity and the planet can thrive. We operate in 4 sectors: Pharmaceuticals, Climate, Agriculture and Computation, tackling the challenges defining those areas by taking a first principles approach and partnering with leading institutions.

Eckert Life Science Accelerator is an incubator for life science from Berlin in Germany. ELSA invests primarily in biotech, pharmaceutical, or medtech start-ups who are in need of seed or A-round venture capital financing. It actively supports founders on their way to valuable and sustainable business models.

EPFL Startup Launchpad empower startups incubated at EPFL by providing funding and support. EPFL (Ecole Polytechnique Fédérale de Lausanne) is one of two Swiss Federal Institutes of Technology. Its location on the shores of Lake Geneva, EPFL brings together a campus of more than 10,000 people. By its novel structure, the school stimulates collaboration between students, professors, researchers and entrepreneurs.

Rejuveron Life Sciences is a fully integrated biotechnology platform company that invests in people and ideas to develop therapies. Rejuveron is a clinical-stage biotechnology company creating therapies to improve healthy aging. Its experienced drug discovery and development team applies a deep understanding of the biology of aging, alongside technological advances in biopharmaceutical R&D, to progress a new generation of medicines that will help people age better and live longer.

Thuja Capital invests in early stage medical product innovations. Thuja Capital is an early-stage venture capital firm located in Utrecht, The Netherlands. We invest in product focused companies that aim to have true impact for patients and doctors alike, as demonstrated in clinical studies to enable a health claim. Hence most of our ventures are active in the field of therapeutics, medical devices and digital health.